A 1-year follow-on study from a randomised, head-to-head, multicentre, open-label study of two pandemic influenza vaccines in children.

Pandemic influenza A H1N1 infections occurred worldwide from 2009. Children were particularly vulnerable. Novel vaccines were used during the pandemic. To assess the persistence of antibody to H1N1 influenza 1 year after children aged 6 months to 12 years had been immunised with two doses of either...

Full description

Bibliographic Details
Main Authors:	de Whalley, P, Walker, W, Snape, MD, Oeser, C, Casey, M, Moulsdale, P, Harrill, C, Andrews, N, Hoschler, K, Thompson, B, Jones, C, Chalk, J, Kerridge, S, Tomlinson, R, Heath, P, Finn, A, Faust, S, Miller, E, Pollard, A
Format:	Journal article
Language:	English
Published:	2011

A 1-year follow-on study from a randomised, head-to-head, multicentre, open-label study of two pandemic influenza vaccines in children.

Similar Items